SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as investors anticipate its optical interposer technology will be critical for next-generation AI data centers, fueled by strategic partnerships with industry giants like Luxshare and Foxconn that indirectly support hyperscalers like Meta and NVIDIA. The community is buzzing about POET's patented passive alignment process, which promises to revolutionize high-volume optical module manufacturing by enabling superior speed and energy efficiency over traditional copper. While eagerly awaiting official news, the market speculates on significant production orders ramping up by 2026, positioning POET as a potential leader in the rapidly expanding photonics sector.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending after receiving positive FDA feedback, which significantly de-risks the regulatory pathway for sonelokimab in hidradenitis suppurativa by allowing reliance on existing trial data for BLA submission. This development has fueled widespread community speculation around potential acquisition bids from major pharmaceutical companies like Merck and Eli Lilly, intensifying discussions about the drug's long-term value and multi-indication potential.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. It operates through the OSS and OSS Europe segments. The company was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems is trending amid strong market interest in edge computing solutions for the defense sector, recently bolstered by a new pre-production order from a major U.S. defense contractor. The community is buzzing with anticipation for a much larger situational awareness system contract, viewing the company as a key player in a rapidly expanding industry with a low share float.

American Battery Technology Co. is a technology company, which engages in the development and marketing of lithium-ion batteries. Its projects include recycling plant, United States Advanced Battery Consortium (USABC), and Tonopah flats. The company was founded on October 6, 2011 and is headquartered in Reno, NV.

American Battery Technology Company

American Battery Technology Company is trending with significant bullish momentum, fueled by strong community sentiment surrounding its role in the U.S. critical minerals and battery recycling sector. Investors are actively discussing the impact of rising lithium prices and the company's strategic positioning amidst government initiatives like the G7 summit on critical metals, anticipating future growth and potential project milestones. Many believe ABAT is poised for substantial appreciation as demand for domestic battery materials heats up.

Volatility Shares Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

UVIX is trending as geopolitical tensions, notably around Venezuela, fuel community debate over potential market volatility, with many anticipating a significant spike amidst broader economic concerns like debt and an AI bubble. Despite overall market resilience, traders are sharply divided, actively discussing hedging strategies and drawing parallels to past market crashes, even as others caution against the ETF's inherent decay.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining is trending due to recent high-grade silver drill results and anticipation for an updated resource estimate in Q1 2026, alongside continued significant investment from Eric Sprott. The community is actively debating the company's vast undeveloped potential amidst a global silver shortage and increasing industrial demand, while also considering the speculative nature and potential for future dilution. This places HYMC at the forefront of discussions regarding domestic precious metal resources in a tightening market.

Lulu's Fashion Lounge Holdings, Inc. engages in providing an online website for clothing. It offers retailing of women's clothing, shoes, and accessories. The company was founded in 1996 and is headquartered in Chico, CA.

Lulus Fashion Lounge Holdings Inc

Lulu's Fashion Lounge Holdings (LVLU) is generating significant buzz and volume after Friedland Enterprises disclosed a substantial stake, pushing for immediate governance reforms. The community is heavily discussing Friedland's strong belief that the stock is profoundly undervalued compared to its peers, citing a considerable valuation gap. This activist involvement and proposed operational improvements are driving widespread speculation about the company's potential for a major re-rating and sustained price movement.

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It also offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Louisville, CO.

Biodesix Inc

Biodesix (BDSX) is trending after releasing strong preliminary fourth quarter and full-year 2025 results, which reported significant revenue growth and reaffirmed Adjusted EBITDA positivity. This announcement has ignited massive trading volume and a sharp increase in share price, leading to community discussion around a potential short squeeze and significant upside, alongside concerns about future dilution risks.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as digital video compact disc player, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

Taiwan Semiconductor (TSM) is trending due to reports of an impending US-Taiwan trade agreement that could significantly expand its manufacturing presence in Arizona, alongside robust revenue growth and optimistic analyst upgrades. The community is actively discussing TSM's critical role as the backbone of the AI sector, driven by surging chip demand and its strategic advancements in packaging capacity amid evolving geopolitical considerations.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is seeing intense trading volume and significant volatility after releasing interim Phase 2 data for its cystic fibrosis therapy, ARCT-032, which showed encouraging mucus plug reduction but limited lung function improvement, leading to a sharp sell-off. The community is debating whether this represents an overreaction and a buying opportunity, given the drug's biological activity and potential for higher doses, or if it signals deeper concerns about the company's valuation and delayed regulatory submissions for other programs. Further discussions revolve around high short interest and a pending trade secret lawsuit, intensifying the stock's unpredictable movements.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Subsea 7 (SUBCY) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Shell Awards Vallourec for Major OCTG Contract at the Orca Project

SHEL awards Vallourec a major OCTG contract for the Orca deepwater project offshore Brazil, covering pipes, services and full well requirements.

Eni's Cronos Development May Add New Gas Volumes to Europe From 2027

E considers moving ahead with the Cronos gas project off Cyprus, which could supply natural gas to Europe by 2027.

XOM Warns of Q4 Upstream Earnings Hit Over Lower Liquids Prices 

ExxonMobil warns Q4 upstream earnings may drop $800M-$1.2B on lower liquids prices, with gas swings and mixed impacts across product margins.

Equinor Challenges Government Order Against Empire Wind Construction 

EQNR has filed a lawsuit challenging the U.S. Interior Department's suspension order against the construction of its Empire Wind offshore wind project.

Transocean's New Deals in Brazil & Norway Add $168M to Firm Backlog

RIG secures work in Brazil and Norway with BP and Equinor contracts that add about $168M to the firm's backlog across two offshore rigs.

3 Reasons Why Growth Investors Shouldn't Overlook Subsea 7 (SUBCY)

Subsea 7 (SUBCY) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Should Value Investors Buy Oceaneering International (OII) Stock?

COP's Australian Drilling Campaign Yields Unexpected Gas Encounter 

ConocoPhillips hits unexpected gas at Charlemont-1 in Australia's Otway Basin, pausing drilling amid high-pressure conditions at Waarre C.

Best Income Stocks to Buy for December 30th

IVR, SUBCY and ESCA made it to the Zacks Rank #1 (Strong Buy) income stocks list on December 30, 2025.

Subsea 7 SA engages in the provision of engineering and construction services to the offshore drilling industry. It provides cost-effective technical solutions to enable the delivery of complex projects in all water depths and challenging environments. The company was founded on March 10, 1993 and is headquartered in London, the United Kingdom.

Subsea 7 S.A. - ADR

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

Current Price	$21.16
Prev Close	$20.95
Open	$20.95
Dividend Yield	7.37%
50-Day Moving Average	$19.42
Beta	0.72
Avg. Volume	9,011.64
PE Ratio	21.66

52-Week High	$21.64
52-Week Low	$12.15
Market Capitalization	$6.26B
EPS (Annual)	$0.6742
Price to Book	1.47
Revenue Per Employee	$452,821.31
Enterprise Value/EBITDA	N/A

SUBCY
Acergy SA

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SUBCY News

SUBCYAcergy SA